← Open Payments lookup

GEDEON LONGTCHI: Open Payments

NPI 1689157331 · CROFTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,654 in 115 payments from 9 companies in 2025. Trend: 2023 $1,208 · 2024 $1,772 · 2025 $2,654

Food & beverage: $2,615Education: $39
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)38$1,017
Otsuka America Pharmaceutical, Inc.15$397
Alkermes, Inc.23$393
ABBVIE INC.13$252
E.R. Squibb & Sons, L.L.C.11$205
Vanda Pharmaceuticals Inc.5$161
Teva Pharmaceuticals USA, Inc.7$151
Lundbeck LLC2$48
Janssen Pharmaceuticals, Inc1$31

Products named: CAPLYTA, ARISTADA, VRAYLAR, COBENFY, REXULTI, FANAPT, ABILIFY ASIMTUFII, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.